Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
40.45
-1.50 (-3.58%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Rapport Therapeutics Employees
Rapport Therapeutics had 84 employees as of December 31, 2025. The number of employees increased by 15 or 21.74% compared to the previous year.
Employees
84
Change (1Y)
15
Growth (1Y)
21.74%
Revenue / Employee
$238,095
Profits / Employee
-$1,632,857
Market Cap
1.94B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 84 | 15 | 21.74% |
| Dec 31, 2024 | 69 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 647 |
| Recursion Pharmaceuticals | 600 |
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Zymeworks | 231 |
| Lakefront Biotherapeutics NV | 196 |
| Kodiak Sciences | 141 |
| Mesoblast | 108 |
RAPP News
- 4 days ago - Rapport Therapeutics price target raised to $75 from $65 at BTIG - TheFly
- 11 days ago - Rapport Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 18 days ago - Rapport Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 27 days ago - Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program - GlobeNewsWire
- 4 weeks ago - Rapport Therapeutics price target raised to $75 from $68 at Raymond James - TheFly
- 4 weeks ago - Rapport Therapeutics price target raised to $66 from $40 at H.C. Wainwright - TheFly
- 6 weeks ago - Rapport Therapeutics reports Q2 EPS ($1.19), consensus (99c) - TheFly
- 6 weeks ago - Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update - GlobeNewsWire